OpenAI Launches GPT-5.6
OpenAI is launching a limited rollout of its GPT-5.6 lineup, introducing three tiers, including the flagship model Sol, with a wider release expected in the coming weeks
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
7 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Anthropic: AI Agents Rise
Anthropic's Economic Index reveals increasing use of autonomous AI agents for complex tasks, with users expecting AI to handle more workload in the next year
AbbVie Buys Apogee
AbbVie is acquiring Apogee Therapeutics, a biotech company developing an experimental eczema drug, for $10.9 billion
AbbVie Buys Apogee
AbbVie is acquiring Apogee Therapeutics, a biotech company developing an experimental eczema drug, for $10.9 billion
AbbVie Buys Apogee
AbbVie is acquiring Apogee Therapeutics, a biotech company developing an experimental eczema drug, for $10.9 billion.
AbbVie Buys Apogee
AbbVie is closing in on a nearly $11 billion deal for biotech company Apogee Therapeutics
AbbVie Buys Apogee
AbbVie is closing in on a nearly $11 billion deal to acquire biotech company Apogee Therapeutics